Sol Gel Technologies Ltd Revenue per Employee (SLGL), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Sol gel Technologies Ltd   (NASDAQ: SLGL)
 

Sol Gel Technologies Ltd 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Sol Gel Technologies Ltd 's Revenue per employee fell on a trailing twelve month basis to $ 10,471, below the company average number of $3,865.
Within the Healthcare sector Employees of 572 other companies have achieved higher revenue per employee. While Sol Gel Technologies Ltd 's total ranking has deteriorated compared to the previous quarter from 1538 to 3942. Sol Gel Technologies Ltd has 3,500 employees.


What is Sales per Employee Ratio?







SLGL Revenue per Employee (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 68.04 % - 217.71 % - 642.47 %
Sales per Employee (TTM) $ 10,471 8,228 8,228 4,849 4,849
SLGL's Total Ranking # 3942 # 1538 # # #
Seq. Revenue Change - - - - -


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 216
Healthcare Sector # 573
Overall Market # 3942

Revenue per Employee Statistics
High Average Low
$ 8,935 $ 3,865 $ 444
(Dec 31 2021)   (Dec 31 2023)



Financial Statements
Sol Gel Technologies Ltd 's Revenue MRQ $ 19 Millions Visit SLGL's Income Statement
Sol Gel Technologies Ltd 's Revenues TTM $ 37 Millions Visit SLGL's aggregate revenue growth
What are SLGL's Sales? Visit SLGL's Sales by Segment




Other Ratios
Sol Gel Technologies Ltd 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
SLGL's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for SLGL's Competitors
Revenue per Employee for SLGL's Suppliers
Revenue per Employee for SLGL's Customers

You may also want to know
SLGL's Sales Growth Rates SLGL's Pe Price to earnings ratio SLGL's Receivables Turnover Ratio SLGL's Stock Quote
SLGL's Net Income Growth Rates SLGL's Ps Price to Sales ratio SLGL's Sales per Employee SLGL's Asset Turnover Ratio
SLGL's Net Margin SLGL's Pb Price to Book ratio SLGL's Financial Strength Ratios SLGL's Dividend Payout Ratio
Date modified: 2026-07-07T13:17:18+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Roivant Sciences Ltd   17,746.67 $ 13.310  Million 750 
Crispr Therapeutics Ag  17,462.69 $ 3.510  Million 201 
Lyra Therapeutics Inc   14,740.74 $ 0.398  Million 27 
Northwest Biotherapeutics Inc  13,123.81 $ 1.378  Million 105 
Crinetics Pharmaceuticals Inc   12,956.23 $ 7.696  Million 594 
Scinai Immunotherapeutics Ltd  12,605.77 $ 1.311  Million 104 
Redhill Biopharma Ltd   11,916.67 $ 0.286  Million 24 
Skinvisible Inc   10,000.00 $ 0.020  Million
Lightwave Logic Inc   6,966.32 $ 0.237  Million 34 
Aclarion Inc   6,884.55 $ 0.076  Million 11 
Silence Therapeutics Plc  6,352.27 $ 0.559  Million 88 
Sol gel Technologies Ltd   5,539.43 $ 19.388  Million 3,500 
Co diagnostics Inc   5,412.95 $ 0.622  Million 115 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.